EQS
Equus Total Return, Inc.
There isn't enough reported data to score EQS yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
EQS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| N/A | |
| N/A |
EQS's profitability is currently under pressure. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like EQS.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
EQS PE Valuation
EQS has no meaningful PE right now: it lost money over the past year.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
EQS Forward outlook
There aren't enough analyst estimates for EQS to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
EQS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.36 | -$0.12 |
| Q1 2026 | -$1.04 | -$0.10 |
| Q4 2025 | -$1.03 | +$0.33 |
| Q3 2025 | -$1.13 | -$0.63 |
| Q2 2025 | -$1.24 | -272% |
| Q1 2025 | -$0.94 | -208% |
| Q4 2024 | -$1.36 | -242% |
| Q3 2024 | -$0.50 | -162% |
EQS lost $1.36 per share over the past year, about the same as its loss the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over EQS on earnings quality, reporting a profit while its opponent remains loss making.
EQS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2021 | $1.4M | -58% |
JPM has the stronger quarterly revenue trend. Revenue is down 29% for EQS versus up 8.1% for JPM.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -455% | N/A |
| Q1 2026 | 78% | N/A |
| Q4 2021 | 15% | N/A |
| Q3 2021 | 67% | N/A |
| Q2 2021 | 46% | -31 points |
| Q1 2021 | 23% | N/A |
| Q2 2020 | 77% | N/A |
| Q3 2019 | 52% | N/A |
EQS's operating margin was −455% last quarter, down 501 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over EQS on profitability, with a higher operating margin.
EQS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $7K | +$1.6M |
| Q4 2025 | -$196K | -100% |
| Q1 2025 | -$1.6M | +$9.8M |
| Q4 2024 | $53.6M | +$87.5M |
| Q3 2024 | -$1.8M | +$5.9M |
| Q2 2024 | -$2.1M | +$2.1M |
| Q1 2024 | -$11.4M | -$5.9M |
| Q4 2023 | -$33.9M | -$31.1M |
JPM has the stronger cash trend. Its trailing FCF is down 229% versus its history, compared with EQS at down 275%.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
EQS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -19% | -3.3M shares |
| 1 year | +2.8% | +381K shares |
| 3 years | +3.3% | +449K shares |
| 5 years | +3.3% | +449K shares |
| Available history | +3.3% | +449K shares |
EQS has 14M diluted shares, up 2.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over EQS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
EQS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -8.0x | Net Cash |
| Q4 2019 | 7.7x | High |
| Q3 2019 | 6.9x | High |
EQS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like EQS.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
EQS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.5 | Oversold |
| Stochastic | 6.9 | Oversold |
EQS's weekly RSI is 26 (oversold) and its Stochastic is 7 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
EQS PE vs Financial Services Sector
| Metric | EQS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
EQS has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
EQS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.78 | 31% below |
| 20 week MA | $0.98 | 45% below |
| 50 week MA | $1.26 | 57% below |
| 100 week MA | $1.36 | 60% below |
| 200 week MA | $1.41 | 62% below |
EQS is in a downtrend: it's below all five of its weekly moving averages, and 62% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over EQS on trend strength, trading above more of its moving averages.
EQS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.67 | $2.18 | +31% |
| 2021 | $2.18 | $2.36 | +8.3% |
| 2022 | $2.36 | $1.63 | -31% |
| 2023 | $1.63 | $1.45 | -11% |
| 2024 | $1.45 | $1.10 | -24% |
| 2025 | $1.10 | $1.66 | +51% |
| 2026 YTD | $1.66 | $0.54 | -67% |
EQS has finished lower in three of the last six years. It's down 67% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over EQS on returns for 2026, with the stronger performance.